Home › Compare › CTCXW vs EQR

CTCXW vs EQR: Dividend Comparison 2026

CTCXW yields 7490.64% · EQR yields 5.87%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 CTCXW wins by $3219325239215192.50M in total portfolio value
10 years
CTCXW
CTCXW
● Live price
7490.64%
Share price
$0.03
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$3219325239215192.50M
Annual income
$3,136,944,464,329,217,000,000.00
Full CTCXW calculator →
EQR
EQR
● Live price
5.87%
Share price
$59.15
Annual div
$3.47
5Y div CAGR
15.8%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$47.8K
Annual income
$5,475.61
Full EQR calculator →

Portfolio growth — CTCXW vs EQR

📍 CTCXW pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodCTCXWEQR
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, CTCXW + EQR cover 0 of 12 months — good coverage

Jan
—
Feb
—
Mar
—
Apr
—
May
—
Jun
—
Jul
—
Aug
—
Sep
—
Oct
—
Nov
—
Dec
—
CTCXW pays
EQR pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

CTCXW
Annual income on $10K today (after 15% tax)
$636,704.12/yr
After 10yr DRIP, annual income (after tax)
$2,666,402,794,679,834,000,000.00/yr
EQR
Annual income on $10K today (after 15% tax)
$499.01/yr
After 10yr DRIP, annual income (after tax)
$4,654.27/yr
At 15% tax rate, CTCXW beats the other by $2,666,402,794,679,834,000,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of CTCXW + EQR for your $10,000?

CTCXW: 50%EQR: 50%
100% EQR50/50100% CTCXW
Portfolio after 10yr
$1609662619607596.25M
Annual income
$1,568,472,232,164,608,400,000.00/yr
Blended yield
97.44%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on EQR right now

CTCXW
No analyst data
Altman Z
-38.0
Piotroski
4/9
EQR
Analyst Ratings
16
Buy
28
Hold
2
Sell
Consensus: Hold
Price Target
$70.35
+18.9% upside vs current
Range: $63.00 — $78.50
Altman Z
1.8
Piotroski
7/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

CTCXW buys
0
EQR buys
0
No recent congressional trades found for CTCXW or EQR in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricCTCXWEQR
Forward yield7490.64% ✓5.87%
Annual dividend / share$2.00$3.47 ✓
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%15.8% ✓
Portfolio after 10y$3219325239215192.50M ✓$47.8K
Annual income after 10y$3,136,944,464,329,217,000,000.00 ✓$5,475.61
Total dividends collected$3213812604182292.00M ✓$23.0K
Payment frequencyquarterlyquarterly
SectorStockREIT

Year-by-year: CTCXW vs EQR ($10,000, DRIP)

YearCTCXW PortfolioCTCXW Income/yrEQR PortfolioEQR Income/yrGap
1← crossover$759,764$749,063.67$11,380$679.82+$748.4K → CTCXW
2$54,000,925$53,187,977.91$13,014$837.25+$53.99M → CTCXW
3$3,590,852,097$3,533,071,107.68$14,961$1,036.20+$3590.84M → CTCXW
4$223,408,125,107$219,565,913,362.68$17,297$1,289.22+$223408.11M → CTCXW
5$13,005,862,347,544$12,766,815,653,679.31$20,121$1,613.15+$13005862.33M → CTCXW
6$708,523,022,229,903$694,606,749,518,031.20$23,561$2,030.84+$708523022.21M → CTCXW
7$36,122,824,222,390,480$35,364,704,588,604,476.00$27,783$2,573.54+$36122824222.36M → CTCXW
8$1,723,706,063,164,109,000$1,685,054,641,246,151,400.00$33,013$3,284.39+$1723706063164.08M → CTCXW
9$76,991,378,398,107,710,000$75,147,012,910,522,120,000.00$39,547$4,223.51+$76991378398107.69M → CTCXW
10$3,219,325,239,215,192,500,000$3,136,944,464,329,217,000,000.00$47,791$5,475.61+$3219325239215192.50M → CTCXW

CTCXW vs EQR: Complete Analysis 2026

CTCXW — Stock

Carmell Therapeutics Corporation focuses on the development of plasma-based bioactive material (PBM) to stimulate tissue repair or growth after injury, disease, and aging. Its lead product candidate is CT-101 bone healing accelerant for tibia fracture healing, foot/ankle fusion, spinal fusion, dental bone graft substitute, and bone void filler; and tissue healing accelerant for androgenetic alopecia and chronic wound healing. The company was founded in 2008 and is based in Pittsburgh, Pennsylvania.

Full CTCXW Calculator →

EQR — REIT

Equity Residential is committed to creating communities where people thrive. The Company, a member of the S&P 500, is focused on the acquisition, development and management of residential properties located in and around dynamic cities that attract high quality long-term renters. Equity Residential owns or has investments in 305 properties consisting of 78,568 apartment units, located in Boston, New York, Washington, D.C., Seattle, San Francisco, Southern California and Denver.

Full EQR Calculator →
📬

Get this CTCXW vs EQR comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

CTCXW vs SCHDCTCXW vs JEPICTCXW vs OCTCXW vs KOCTCXW vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.